These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 17008696

  • 1. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
    Rangel J, Torabian S, Shaikh L, Nosrati M, Baehner FL, Haqq C, Leong SP, Miller JR, Sagebiel RW, Kashani-Sabet M.
    J Clin Oncol; 2006 Oct 01; 24(28):4565-9. PubMed ID: 17008696
    [Abstract] [Full Text] [Related]

  • 2. Osteopontin as a molecular prognostic marker for melanoma.
    Rangel J, Nosrati M, Torabian S, Shaikh L, Leong SP, Haqq C, Miller JR, Sagebiel RW, Kashani-Sabet M.
    Cancer; 2008 Jan 01; 112(1):144-50. PubMed ID: 18023025
    [Abstract] [Full Text] [Related]

  • 3. Novel role for RGS1 in melanoma progression.
    Rangel J, Nosrati M, Leong SP, Haqq C, Miller JR, Sagebiel RW, Kashani-Sabet M.
    Am J Surg Pathol; 2008 Aug 01; 32(8):1207-12. PubMed ID: 18580492
    [Abstract] [Full Text] [Related]

  • 4. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.
    Arch Dermatol; 2008 Apr 01; 144(4):462-7. PubMed ID: 18427039
    [Abstract] [Full Text] [Related]

  • 5. Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.
    Weinlich G, Topar G, Eisendle K, Fritsch PO, Zelger B.
    J Eur Acad Dermatol Venereol; 2007 May 01; 21(5):669-77. PubMed ID: 17447982
    [Abstract] [Full Text] [Related]

  • 6. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.
    Br J Dermatol; 2007 Jul 01; 157(1):58-67. PubMed ID: 17501957
    [Abstract] [Full Text] [Related]

  • 7. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A, Melanoma Group of the European Organization for Research and Treatment of Cancer.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):472-82. PubMed ID: 16595783
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic value of galectin-3 in primary cutaneous melanoma.
    Buljan M, Šitum M, Tomas D, Milošević M, Krušlin B.
    J Eur Acad Dermatol Venereol; 2011 Oct 05; 25(10):1174-81. PubMed ID: 21175876
    [Abstract] [Full Text] [Related]

  • 10. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF.
    J Clin Oncol; 2012 Jul 20; 30(21):2678-83. PubMed ID: 22711850
    [Abstract] [Full Text] [Related]

  • 11. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.
    J Clin Oncol; 2007 Mar 01; 25(7):869-75. PubMed ID: 17327608
    [Abstract] [Full Text] [Related]

  • 12. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S, Browning J, MacGregor D, Pollara G, Scolyer RA, Murali R, Thompson JF, Deb S, Azad A, Davis ID, Cebon JS.
    Eur J Cancer; 2011 Feb 01; 47(3):460-9. PubMed ID: 21115342
    [Abstract] [Full Text] [Related]

  • 13. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma.
    Thies A, Schachner M, Berger J, Moll I, Schulze HJ, Brunner G, Schumacher U.
    J Pathol; 2004 Aug 01; 203(4):933-9. PubMed ID: 15258996
    [Abstract] [Full Text] [Related]

  • 14. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C.
    Cancer; 2008 Apr 15; 112(8):1795-804. PubMed ID: 18306371
    [Abstract] [Full Text] [Related]

  • 15. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
    Gutzmer R, Satzger I, Thoms KM, Völker B, Mitteldorf C, Kapp A, Bertsch HP, Kretschmer L.
    J Dtsch Dermatol Ges; 2008 Mar 15; 6(3):198-203. PubMed ID: 18093216
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.
    Eur J Cancer; 2009 Sep 15; 45(14):2537-45. PubMed ID: 19553103
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
    Wang Y, Dai DL, Martinka M, Li G.
    Clin Cancer Res; 2007 Jul 15; 13(14):4111-6. PubMed ID: 17634537
    [Abstract] [Full Text] [Related]

  • 20. A multimarker prognostic assay for primary cutaneous melanoma.
    Kashani-Sabet M, Venna S, Nosrati M, Rangel J, Sucker A, Egberts F, Baehner FL, Simko J, Leong SP, Haqq C, Hauschild A, Schadendorf D, Miller JR, Sagebiel RW.
    Clin Cancer Res; 2009 Nov 15; 15(22):6987-92. PubMed ID: 19887476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.